Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. The company is headquartered in Cambridge, Massachusetts. Show more

500 BOYLSTON STREET, BOSTON, MA, UNITED STATES, 02116, Boston, MA, 02116, USA

https://www.vorbio.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

1.059B

52 Wk Range

$6.50 - $50.20

Previous Close

$19.55

Open

$19.91

Volume

924,600

Day Range

$19.60 - $21.90

Enterprise Value

570.7M

Cash

169.9M

Avg Qtr Burn

-38.25M

Insider Ownership

4.27%

Institutional Own.

75.30%

Qtr Updated

03/31/26

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Telitacicept Details Sjogren's Disease	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Telitacicept Details Myasthenia gravis	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Telitacicept Details IgA neuropathy (IgAN)	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
VCAR33 (ALLO) Details Acute myeloid leukemia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Trem-cel (VOR33) + VCAR33 Details Acute myeloid leukemia	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Trem-cel (VOR33) + Mylotarg (VBP101) Details Acute myeloid leukemia, Myelodysplastic syndrome	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.